What class of antibiotic is Cefepime (Cefepime)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefepime Classification

Cefepime is a fourth-generation cephalosporin antibiotic. 1

Structural and Chemical Characteristics

  • Cefepime is a semi-synthetic, broad-spectrum cephalosporin with the chemical name 1-[[(6R,7R)-7-[2-(2-amino-4-thiazolyl)-glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium chloride, 72-(Z)-(O-methyloxime), monohydrochloride, monohydrate 1

  • The drug possesses a zwitterionic structure that contributes to more rapid penetration of gram-negative bacterial cell membranes 2, 3

Fourth-Generation Designation Rationale

  • The "fourth-generation" classification reflects cefepime's enhanced spectrum compared to third-generation cephalosporins, combining the gram-positive activity similar to cefotaxime with gram-negative activity comparable to ceftazidime 4, 5, 3

  • Cefepime demonstrates activity against many organisms that are resistant to third-generation cephalosporins, including derepressed mutants of Enterobacter species 5

  • The drug exhibits stability against many common plasmid- and chromosomally-mediated beta-lactamases and is a poor inducer of type I (AmpC) beta-lactamases 4, 5

Distinguishing Features from Other Cephalosporin Generations

  • Fourth-generation cephalosporins like cefepime have activity against AmpC-producing organisms, which distinguishes them from third-generation cephalosporins 6

  • Cefepime has low affinity for most type I beta-lactamases, leading to significantly reduced enzymatic degradation compared with other cephalosporins 2

  • The American College of Clinical Pharmacy notes that cefepime has broader spectrum activity than third-generation cephalosporins, particularly against gram-positive bacteria 7

Clinical Context

  • Cefepime is approved for parenteral administration only (intravenous or intramuscular routes) 1

  • The Infectious Diseases Society of America recommends fourth-generation cephalosporins such as cefepime for severe community-acquired infections requiring broader spectrum coverage 6

References

Research

Cefepime.

Pharmacotherapy, 1994

Research

Cefepime: a fourth-generation parenteral cephalosporin.

The Annals of pharmacotherapy, 1996

Research

Cefepime: a review of its use in the management of hospitalized patients with pneumonia.

American journal of respiratory medicine : drugs, devices, and other interventions, 2003

Guideline

Fourth Generation Cephalosporins

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antimicrobial Coverage of Cefepime-Sulbactam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.